Scotiabank lowered Andlauer Healthcare Group's price target from C$46.00 to C$45.00.

Scotiabank reduced its price target for Andlauer Healthcare Group from C$46.00 to C$45.00, while maintaining a sector perform rating. This follows similar target price adjustments by other institutions, including RBC, Stifel Nicolaus, TD Securities, and CIBC. The average target price for the company is now C$48.57, with a Moderate Buy rating. Andlauer Healthcare Group, which specializes in healthcare logistics and specialized transportation, recently declared a quarterly dividend of $0.10.

August 06, 2024
3 Articles